Study 1 (hypertriglyceridaemic patients) | ||
---|---|---|
Group A (BZB) (n=13) | Group B (ALL) (n=14) | |
Age (years) | 50.4 (2.7) | 50.5 (2.3) |
BMI (kg/m2) | 24.3 (0.6) | 25.5 (0.8) |
T-chol (mmol/l) | 5.60 (0.20) | 5.86 (0.18) |
TG (mmol/l) | 2.87 (0.34) | 3.04 (0.44) |
HDL-chol (mmol/l) | 1.17 (0.08) | 1.30 (0.06) |
S-Cr (μmol/l) | 78 (4) | 70 (3) |
Study 2 (hypertensive patients) | ||
---|---|---|
Group A (BZB) (n=13) | Group B (ALL) (n=12) | |
BZB, benzbromarone; ALL, allopurinol; BMI, body mass index; T-chol, total cholesterol; TG, triglyceride; HDL-chol, high density lipoprotein cholesterol; S-Cr, serum creatinine; SBP, systolic blood pressure; DBP, diastolic blood pressure. | ||
Age (years) | 54.4 (1.5) | 53.7 (2.2) |
BMI (kg/m2) | 24.8 (0.6) | 24.7 (0.7) |
SBP (mm Hg) | 160.0 (3.1) | 161.1 (4.2) |
DBP (mm Hg) | 100.7 (2.4) | 101.2 (1.3) |